The expression of cardiac ankyrin repeat protein in an animal model of adriamycin-induced cardiomyopathy

Korean Circulation Journal

Volumn 38, Issue 9, 2008, Pages 455-461

  Chung, Woo Baek ^a   Youn, Ho Joong ^a   Choi, Yun Seok ^a   Park, Chul Soo ^a   Oh, Yong Seog ^a   Chung, Wook Sung ^a   Kim, Jae Hyung ^a   Lee, Jeong Hwa ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Adriamycin; Ankyrin, repeat; Cardiomyopathies; Hypertension

Indexed keywords

CARDIAC ANKYRIN REPEAT PROTEIN; DOXORUBICIN; NUCLEAR PROTEIN; POLYCLONAL ANTIBODY; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; CONTROLLED STUDY; CYTOPLASM; DRUG INDUCED DISEASE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

EID: 56049125980     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2008.38.9.455     Document Type: Article

References (21)

1. The Korean Society of Hypertension. Prevalence of hypertension. In: 2004 Korean Hypertension Treatment Guidelines 2004. p. 8-15.
2. Takimoto CH. Topoisomerase interactive agents. In: DeVita VT, Hellman S, Rosenberg SA, editos. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 387.
3. Speyer JL, Ewer MS, Freedberg RS. Cardiac effects of cancer therapy. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, editors. Clinical Oncology. Philadelphia: Elsevier Churchill Livingstone; 2004. p. 1252.
4. Uhm JS, Youn HJ, Choi YS, et al. Comparison of adriamycin-induced cardiomyopathy in normotensive rats and spontaneously hypertensive rats. J Korean Soc Hypertens 2006;12:23-30.
5. Zou Y, Evans S, Chen J, Kuo HC, Harvey RP, Chien KR. CARP, a cardiac ankyrin repeat protein, is downstream in the Nkx2-5 homeobox gene pathway. Development 1997;124:793-804.
6. Aihara Y, Kurabayashi M, Saito Y, et al. Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promotor Hypertension 2000;36:48-53.
7. Zolk O, Frohme M, Maurer A, et al. Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochem Biophys Res Commun 2002;293:1377-82.
8. Jeyaseelan R, Poizat C, Baker RK, et al. A novel cardiac-restricted target for doxorubicin: CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. J Biol Chem 1997;272:22800-8.
9. Aihara Y, Kurabayashi M, Tanaka T, et al. Doxorubicin represses CARP gene transcription through the generation of oxidative stress in neonatal rat cardiac myocytes: possible role of serine/theronine kinase-dependent pathways. J Mol Cell Cardiol 2000; 32:1401-14.
10. Aihara Y, Kurabayashi M, Arai M, Kedes L, Nagai R. Molecular cloning of rabit CARP cDNA and its regulated expression in adriamycin-cardiomyopathy. Biochim Biophys Acta 1999;1447: 318-24.
11. Baumeister A, Arber S, Caroni P. Accumulation of muscle ankyrin repeat protein transcript reveals local activation of primary myotube endcompartments during muscle morphogenesis. J Cell Biol 1997;139:1231-42.
12. Nakada C, Oka A, Nonaka I, et al. Cardiac ankyrin repeat protein is preferentially induced in atrophic myofibers of congenital myopathy and spinal muscular atrophy. Pathol Int 2003;53:653-8.
13. de Waard V, van Achterberg TA, Beauchamp NJ, Pannekoek H, de Vries CJ. Cardiac ankyrin repeat protein (CARP) expression in human and murine atherosclerotic lesions: activin induces CARP in smooth muscle cells. Arterioscler Thromb Vasc Biol 2003;23:64-8.
14. Boengler K, Pipp F, Fernandez B, Ziegelhoeffer T, Schaper W, Deindl E. Arteriogenesis is associated with an induction of the cardiac ankyrin repeat protein (carp). Cardiovasc Res 2003;59: 573-81.
15. Weber KT, Jalil JE, Janicki JS, Pick R. Myocardial collagen remodeling in pressure overload hypertrophy: a case for interstitial heart disease. Am J Hypertens 1989;2:931-40.
16. Rossi MA. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertens 1998;16:1031-41.
17. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993;88:993-1003.
18. Singal PK, Li T, Kumar D, Danelisen I, Iliskovic N. Adriamycin-induced heart failure: mechanism and modulation. Mol Cell Biochem 2000;207:77-86.
19. Park CS, Youn HJ, Cho EJ, et al. Cardioprotective effect of IGF-1 in mouse with adriamycin induced cardiomyopathy. Korean Circ J 2002;32:1116-23.
20. Choi YS, Park CS, Cho FJ, et al. The relation between acute adriamycin induced cardiomyopathy and apoptosis in rat: study using 15 MHz high frequency transducer. J Korean Soc Echocardiogr 2002; 10:35-43.
21. Youn HJ, Kim HS, Jeon MH, et al. Induction of caspase-independent apoptosis in H9c2 cardiomyocytes by adriamycin treatment. Mol Cell Biochem 2005;270:13-9.